Pre-, post-exposure prophylaxis effective HIV prevention Valacyclovir reduced HIV-1 levels in patients who did not have the herpes simplex virus 2. The results of a new trial show that a common herpes ...
Although valganciclovir is an effective CMV prophylactic agent after kidney transplantation, it is associated with significant side effects. Valacyclovir (valA) is effective and more tolerable than ...
Data from a randomized, double-blind clinical study found that the use of pritelivir led to a lower percentage of swabs with herpes simplex virus (HSV) detection over 28 days vs. valacyclovir. Full ...
Oral acyclovir has been demonstrated to prevent reactivation of herpes simplex virus (HSV) infections when administered prophylactically to autologous bone marrow transplant (BMT) recipients or ...
NEW YORK (Reuters Health) - Therapy with valacyclovir (Valtrex, GlaxoSmithKline), started within three months of infection with either herpes simplex virus type 1 (HSV-1) or HSV type 2 (HSV-2), ...
An international team of researchers finds that taking a single daily dose of an approved antiviral drug known as valacyclovir can reduce the transmission of genital herpes to uninfected partners by ...
Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir. HealthDay News — One year of valacyclovir is beneficial for patients ...
ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat ...
NDA submission 1 (NDA) to the U.S. Food & Drug Administration (FDA) expected in 2024 Liège, Belgium – December, 26 2023 – 6PM CET – Regulated information – Inside Information - Hyloris Pharmaceuticals ...
Valtrex (valacyclovir) is a brand-name oral tablet that’s prescribed to treat or prevent certain viral infections, including cold sores, genital herpes, shingles, and chickenpox. The cost of the drug, ...
Vestibular neuritis is the second most common cause of peripheral vestibular vertigo. Its assumed cause is a reactivation of herpes simplex virus type 1 infection. Therefore, corticosteroids, ...